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Abstract 
High-dimensional data (HDD) have been encountered in many fields and are 
characterized by a “large p, small n” paradigm that arises in genomic, lipidomic, and proteomic 
studies. This report used a simulation study that employed basic block diagonal covariance 
matrices to generate correlated HDD. Quantities of interests in such data are, among others, the 
number of ‘significant’ discoveries. This number can be highly variable when data are 
correlated. This project compared randomization tests versus usual t-tests for testing of 
significant effects across two treatment conditions. Of interest was whether the variance of the 
number of discoveries is better controlled in a randomization setting versus a t-test. The results 
showed that the randomization tests produced results similar to that of t-tests. 
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Chapter 1 - Introduction 
With the development of modern technologies, high-dimensional data (HDD) have been 
encountered in many fields, especially in areas of biological and medical research. A common 
characteristic of HDD is that the number of features or variables is very large in the dataset, 
while the sample size is relatively small. It refers to a “large p, small n” paradigm (West, 2003) 
that arises in genomic, lipidomic, proteomic, and microarray studies. In particular, microarray 
technology enables researchers to monitor the expression levels of tens of thousands of genes 
simultaneously. The context of the microarray experiments can be found in Allison et al. (2005) 
and Göhlmann et al. (2009). This report will focus on microarray data, but the technical 
discussions are applicable to studies involving HDD. 
A common interest in microarray studies is to detect the genes that are differentially 
expressed because of a treatment effect. In light of this goal, we need to estimate the difference 
in gene expression and test whether the observed differences are induced by treatment or by 
chance. In this process, two important issues emerge. One is the choice of an appropriate 
reference distribution for computing valid P-values. The other is the correlation structure among 
thousands of genes, which can cause correlation among test statistics from multiple tests. See Hu 
et al. (2010) to get more details about invalid P-values due to an incorrect reference distribution. 
Results given by P-values can be misleading if required assumptions are violated. Among 
the various techniques to quantify the difference across levels of treatment for a single gene, the 
student’s t-test is a common choice since it is relatively robust to moderate violations of the 
normality assumption. In addition, the sample means of moderately large samples are 
approximately normal distribution based on the central limit theorem even though the individual 
data values may not be normally distributed (Boneau, 1960; Edgell et al., 1984). 
However, the sample sizes were often small in early microarray experiments because of 
the cost of arrays, and the gene expression may not be normally distributed (Lee et al., 1999). So, 
resampling-based procedures (RBPs) or nonparametric tests became an alternative for 
researchers. RBPs have certain advantages, such as eliminating some parametric assumptions 
and being robust and flexible to accommodate different test statistics (Gadbury et al., 2003). See  
Mehta (2006) to get more details about two RBPs – randomization and the bootstrap.  
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Recently, microarray technologies have become more affordable. For example, a sample 
size of 173 was used for the real case study in this report. Thus, sample size is a lesser limitation 
for the application of a student’s t-test to HDD. However, the correlation structure is still a 
challenge for high-dimensional investigations since many genes are co-regulated in an organism, 
and estimation of the dependence structure is unrealistic because of the very large number of 
features relative to the available samples. In addition, the simulation of realistic data is very 
complicated in practice. Paranagama (2011) discussed the challenges of generating realistic data. 
Most studies used a rigid dependence structure for simulation studies ( Gadbury et al., 2003; Hu 
et al., 2011). Gadbury et al. (2008) proposed a plasmode method for generating data which were 
closer to the structure of real data. Paranagama (2011) extended this method and suggested a new 
plasmode method to simulate data with more original structure preserved in the datasets. 
In this report, we employed a simple rigid dependence structure, i.e., basic block diagonal 
covariance matrices (equicorrelaiton matrices and normal distribution theory) to generate 
correlated data for simulations, so that we can use a correct test statistic to compute the P-value 
for a single gene. Then, the P-values will be valid for all genes and the distribution of P-values 
will be expected to be uniform under the global null hypothesis and no correlation effects. A 
global null hypothesis is defined as the null hypothesis is true for every test. However, the 
distribution of P-values may vary widely from experiment to experiment when the HDD are 
correlated , even under the global null hypothesis. In some cases, there are fewer P-values 
clustering near 0 than expected under the global null hypothesis. In other cases, the distribution 
of P-values is more likely to cluster near 0. In addition, the distribution of P-values is expected to 
be clustering near 0 when the alternative hypothesis is true. So, the distribution of P-values may 
give misleading results when HDD are correlated. 
Next, we will focus on comparison of randomization tests with usual t-tests for testing of 
significant effects across two treatment conditions in correlated HDD. Correlated tests can give 
misleading results, in part because the variance of the number of discoveries is inflated using t-
tests (Hu et al., 2010). So, of interest was whether the variance of the number of discoveries is 
better controlled in a randomization setting versus using a t-test. In fact, a randomization test, 
where entire high-dimensional vectors are permuted across treatment conditions, helps preserve 
the dependence structure in HDD, but it does not accommodate the correlation  effects in high-
dimensional testing situations (Efron, 2007; Efron 2010) .  
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In the context of this research, the results show that the randomization tests produce 
results similar to results from t-tests. When the data are uncorrelated, P-values are valid and the 
distribution of P-values is meaningful to illustrate biological interests. However, the distribution 
of P-values may give misleading results if the data are correlated. Thus, randomization tests are 
no direct assistance with the correlation effects in HDD. 
The remainder of this report is organized as follows. Firstly, some key references will be 
reviewed which are closely related to this field. Then, the simulation studies will be described in 
Chapter 3. In Chapter 4, we will present a real case study involving a microarray experiment. 
Finally, the conclusion and further study will be given in Chapter 5. 
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Chapter 2 - Literature Review 
The investigation of high-dimensional data (HDD) has been an active topic in recent 
research. This chapter will briefly review some literature applicable to this report.  
 2.1 Introduction of high-dimensional data 
High-dimensional data are defined as sets of data in which the number of features 
compared to the sample size is very large. They refer to a “large p, small n” paradigm arising in 
“omics” studies. Among these studies, microarray data are a good example of HDD. For 
microarray studies, two treatment conditions are very common (e.g. Control vs Treatment). The 
following table shows the structure of HDD for two treatment conditions. A measure of genetic 
expression level for the ith gene of the jth experimental unit is denoted by 
 
Yij
c  for control group 
and 
 
Yij
t  for treatment group. 
 
Table 2.1 HDD structure for two treatment conditions 
 
 
 
 
 
 
 
 
 
 
In microarray data analysis, of interest is to identify the genes that are differentially 
expressed between two treatment groups. So, multiple tests are performed for K features 
simultaneously. This inflates  the number of type I errors because K is very large and the 
probability is k)1(1 α−− for at least one is falsely rejected null hypothesis. There are several 
conventional methods employed to deal with this problem by controlling FWER (i.e., the 
 Control Treatment 
         EU 
i  
  1 … 
1n  1 … 2n  
1 cY11  … cnY 11  
tY11  … tnY 21  
… c
iY 1  … cinY 1  
t
iY 1  … tinY 2  
K c
kY 1  … cknY 1  
t
kY 1  … tknY 2  
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probability of one or more Type I errors), such as Bonferroni, Dunett, Tukey, ect. But they are 
too conservative when the number of comparisons is very large. Take the Bonferroni method for 
example, it sets the significance cut-off at α/K which is a very small value when K is large and it 
is known to be too  conservative for HDD analysis. In our real case study, the significance cut-
off is at 0.05/3790 =1.32x10-5 if we want to control FWER at 0.05. It is too conservative and may 
fail to detect the genes that are differentially expressed between two conditions. 
In 1995, Benjamini and Hochberg proposed their landmark work by introducing the false 
discovery rate (FDR). FDR is the expected proportion of false findings among all significant 
discoveries. Let K be the total number of tests, R be the significant discoveries at some 
threshold, and P be the number of non-significant results. In a real dataset, only these three 
measures are known. Other accuracy measures are given in Table 2.2. Then, FDR is defined by 





=
>
=
0
0
0
)/(
R
RRVE
FDR . In addition, Benjamini and Yekutieli (2001) proved that the same 
procedure with a slight modification controlled the false discovery rate under a particular  
positive dependency structure. Pawitan et al. (2006) developed a procedure for estimating FDR 
using a latent variable approach under general dependence. 
 
Table 2.2 Notations for accuracy measures 
 
 
 
 
 
 
 
L is the number of true null hypotheses 
M is the number of true alternative hypotheses 
V is the number of false positives (Type I error) 
S is the number of true positives 
T is the number of false negatives (Type II error) 
 True Ho True Ha Total 
Declared significant V S R 
Declared non-significant U T P 
Total L M K 
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U is the number of true negatives 
Storey (2002) defined the FDR as | 0 ( 0)VFDR E R P R
R
 = > > 
 
 and “positive” false 
discovery rate (pFDR) as | 0VpFDR E R
R
 = > 
 
. The q value is a measure of significance in 
terms of FDR. It is the minimum pFDR at which the individual test may be significant. The q-
value is calculated as follows (Storey, 2002): 
For the K hypothesis tests, compute the P-values 
 
P1,...,PK . 
Order the P-values 
 
P(1) ≤ ...≤ P(K ). 
Set 
 
ˆ q(P(K )) = pF ˆ D R(P(K )) . 
Set 
 
ˆ q(P(i)) = min pF ˆ D R(P(i)), ˆ q(p( i+1)){ } for i=K-1, K-2, …, 1. 
 2.2 Application of t-test and randomization test in HDD study 
For comparison of two treatment conditions, a two-sample t-statistic is often computed 
for testing of the significance. Allison et al. (2002) employed this parametric approach to 
produce a P-value and then used a mixture model (uniform distribution and beta distribution) on 
a distribution of P-values to analyze the gene expression data. Pawitan (2005) illustrated the 
necessity of FDR for analysis of microarray data by applying the usual t-test. Cao (2011) 
suggested a method to produce the simultaneous critical values for rejection regions by using t-
statistics.  
As we mentioned before, the sample sizes are small in the early microarray studies and 
the assumptions of the parametric approach may not always be met. Thus, randomization tests 
have some advantages to be considered as an alternative. Gadbury et al. (2003) relied on 
‘nonparametric’ randomization tests to produce an exact P-value for each gene under an additive 
model when the small sample size is small. They also showed that the distribution of P-values on 
all genes can yield valuable information to answer the biological question – whether the gene 
expression levels are significantly different between control and treatment group. Barry et al. 
(2005) described a permutation-based framework, significance analysis of function and 
expression (SAFE) to analyze data from  gene expression studies. Subramanian et al. (2005) 
proposed a method called gene set enrichment analysis (GSEA), and then did permutations to 
compute the statistics for assessing the significant gene-sets. Efron and Tibshirani (2007) 
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suggested two improvements to GSEA. Dudoit (2002) used a permutation procedure to detect the 
differentially expressed genes by estimating the adjusted P-values. Hall and Tajvide (2002) 
suggested a permutation approach to test the equality of distributions in an HDD setting. In 
addition, some researches are involved in the comparison of t-tests and permutation tests. Tsai et 
al. (2003) compared the type I error and power of the t-tests and permutation test for detecting 
differentially expressed genes between two microarray sample sets.  
 2.3 Correlation effects in HDD analysis 
Since many genes are co-regulated in an organism, correlation exists among gene 
expression levels (Qui et al., 2005). It is a challenge for investigating HDD because it is 
unrealistic to estimate the dependence structure, and difficult to simulate realistic data (Hu et al., 
2010; Paranagama, 2011).  
In 2010, Hu et al. illustrated the distribution of P-values in HDD analysis. They  showed 
that a histogram of valid P-values is expected to be approximately uniform between 0 and 1 
under the global null hypothesis. But when the valid P-values are correlated, the distribution of 
P-values under the global null hypothesis may vary widely from experiment to experiment and 
may give us misleading results. Also, the research showed that the P-values are no longer 
expected to be uniformly distributed under the global null hypothesis if they are computed from 
incorrect statistical tests.  
In addition, Hu et al. (2010) discussed the issues about correlated P-values under the 
global null hypothesis. They adopted the idea of Schweder and Spjøtvoll (1982) and simulated 
the test statistics using a restrictive  dependence structure, which means that all pairwise 
correlations of two test statistics are equal within a block while the test statistics are uncorrelated 
in different blocks. Let pi be a P-value for the ith feature, α be a threshold, m be the number of 
blocks, and bN  be the number of tests declared not significant for one block with size b. 
iD  is defined as follows, 





>
≤
=
α
α
i
i
i
p
p
D
1
0
, which is a Bernoulli variable. Then, bN  is the 
summation of iD . The expected value of bN  is )1()(
1
00
α−=





= ∑
=
bDENE
b
i
iHbH and the 
8 
 
variance of bN  is ),()1()1()( 21
1
00
DDCovbbbDVNV
b
i
iHbH −+−=





= ∑
=
αα . The covariance of 
1D  and 2D is given as,  
 
            22121 )1()1,1(),( α−−=== DDPDDCov  
                                
,)1(),(
),(),(),(
)1(),(
2
2/2/
2/2/2/2/2/2/
2
2/22/1
α
α
αα
αααααα
αα
−−−−Φ+
−Φ−−Φ−Φ=
−−≤≤=
zz
zzzzzz
zTzTP
 
where T1 and T2 represent two test statistics with correlation equal to ρ, Φ(z1, z2) is a bivariate 
normal CDF of (T1, T2) evaluated at (z1, z2). Let 0N be the number of genes declared 
significant out of total K genes under the global null hypothesis. Then, the expected value of 0N  
is 
 
E H0 (N0) = Kα  and the variance of 0N  is )()( 00 bH NmVarNV = . 
 2.4 Relationship between dependence structure and correlation of test 
statistics 
Paranagama (2011) discussed the conditional density of test statistics and illustrated the 
relationship between dependence structure of the data and correlation of two test statistics. The 
equation is given by 
))(( 2222 jjii
jiyjix
zij τστσ
ττρσσρ
ρ
++
+
= , where it is assumed that two features within a 
group have a bivariate normal distribution. For this equation, xρ  represents the correlation 
between the ith and jth features in group 1, 
 
ρy denotes the correlation between these two features 
in group 2, and σ  and τ  are the variances for these two features in two groups, respectively.  
For the rigid dependence structure, it is assumed that the correlations are the same 
between two features in two groups and the variances are also the same. Thus, this formula could 
be simplified by ρ
σσ
ρσρ ==
22
2
2*2
2
ijz
, which means that the correlation between two test 
statistics is the same as two features in the dataset. 
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Chapter 3 - Simulation Study 
In this section, the results are reported from simulation studies which were designed to 
compare the performance of randomization tests with usual t-tests. Figure 3.1 depicts the 
procedure for the simulation study. First, the HDD need to be generated. Then, both t-test and 
randomization test are employed to analyze the created datasets and a P-value from a test for 
each gene is calculated using these two tests. Based on P-values, we can get a list of significant 
discoveries by counting the number of statistically significant tests, one of the quantities of 
interests for this research. This simulation is repeated 200 times to compute the mean and 
standard deviation of the number of discoveries. Finally, the results of randomization tests are 
compared with that of t-tests. For a randomization setting, it is column-wise permutation 
meaning that the entire high-dimensional samples are permuted across the two treatment 
conditions. 
 
Figure 3.1 Procedure for Simulation Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20
0 
tim
es
 
Generate Data 
Randomization 
test 
P-values 
Analysis 
P-values 
List of significant 
discoveries 
List of significant 
discoveries 
T-test 
200 tim
es 
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 3.1 Simulating high-dimensional datasets 
For simulating the data, basic block diagonal covariance matrices in a multivariate 
normal distribution are employed to create the correlated HDD, where the correlation structure is 
easily parameterized. The datasets are generated for a total of 1000 genes for two treatment 
conditions (K=1000, G=2). A 200 × 200 equicorrelation matrix (
 
200∑ ) is used to incorporate 
the correlation into the simulations, which has 1 on the diagonal entries and ρ  on the off-
diagonal entries. Thus, the correlation between all pairs is ρ  within each block, and the features 
are uncorrelated in different blocks. This simulation study used only non-negative values for ρ  
since the equicorrelation block diagonal matrix was not positive definite when ρ < 0. In addition, 
we assumed that the dependence structure among genes is the same in the two treatment groups 
and that the expression levels of the same gene are independent in different samples (arrays).  
In this study, there were a total of 18 cases for the simulation study based on different 
means, sample sizes, and correlations. We generated expression levels on 1000 genes and n 
samples for each group, where n=10 and 20. For the genes chosen to be differentially expressed, 
data were generated using a mean corresponding to an effect size on the standard normal scale. 
On average, 25% of the features were simulated as differentially expressed genes between the 
two groups. So, 250 genes had a higher average expression in the treatment group, while others 
were not differentially expressed in the two groups. For the different correlations, we changed ρ  
over 3 values of 0 (independence), 0.3 (moderate dependence), and 0.6 (strong dependence). In 
addition, variances were set equal to 1. The details of parameters are displayed in table 3.1. 
 3.2 Quantities of interests 
One of the quantities of interests is the P-values. Since the simulation is repeated 200 
times, there are 200 vectors of P-values with a length of 1000. We count the number of 
significant discoveries based on P-values that are below a threshold, and denote this number as 
No. In this study, 3 thresholds were used. For each threshold, there were 200 numbers for the 
counts of significance. Based on these numbers, the empirical values were computed for the 
mean and standard deviation of No. In addition, the theoretical values also can be calculated for 
some cases based on the theories mentioned in the literature review. 
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Table 3.1 Cases for the Simulation Study 
 
  
 3.3 Results of the simulation studies 
The focus of the simulation was to assess the performance of randomization tests 
compared to t-tests. Of interest was whether the variance of the number of discoveries is better 
controlled in a randomization setting for correlated HDD.  
 3.3.1 Correlated P-values on the number of significant discoveries 
The empirical values were compared between t-tests and randomization tests for mean 
and standard deviation of the number of significant discoveries. Also, the theoretical values were 
Cases Sample Size (n) Correlation ( ρ ) Standardized 
Effect Size 
Controlµ  Treatmentµ  
1 20 0 0 0 0 
2 20 0.3 0 0 0 
3 20 0.6 0 0 0 
4 10 0 0 0 0 
5 10 0.3 0 0 0 
6 10 0.6 0 0 0 
7 20 0 1.58 0 0.5 
8 20 0.3 1.58 0 0.5 
9 20 0.6 1.58 0 0.5 
10 10 0 1.58 0 0.7 
11 10 0.3 1.58 0 0.7 
12 10 0.6 1.58 0 0.7 
13 20 0 3.16 0 1 
14 20 0.3 3.16 0 1 
15 20 0.6 3.16 0 1 
16 10 0 3.16 0 1.4 
17 10 0.3 3.16 0 1.4 
18 10 0.6 3.16 0 1.4 
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compared with empirical values under the global null hypothesis. The outcomes are displayed in 
table 3.2-3.4 showing that the randomization tests produce similar results to the t-tests. SS 
represents the sample size and ES represents effect size for each group on a standardized scale. 
In cases 1-6, the effect size is 0, meaning that no genes are differentially expressed across the 
two treatment groups (that is, the global null hypothesis is true). In cases 7-12, the effect size is 
1.58, meaning that some genes are differentially expressed across the two treatment groups. In 
cases 13-18, it is also for the simulations under the alternative hypothesis; however, the effect 
size is twice the cases of 7-12. E(No) is the expected number of significant discoveries out of 
1000 genes. Sd(No) is the standard deviation of the number of significant discoveries.  
As mentioned in the literature review, the expected number of differentially expressed 
genes is 
 
Kτ  under the global null hypothesis. It only depends on the threshold 
 
τ  for 
significance. If the global null hypothesis is true, it is expected that there will be 
 
Kτ  statistically 
significant tests (genes). These are then type I errors if the global null hypothesis is true. If the 
number of rejected null hypothesis substantially exceeds the expected value under the global null 
hypothesis, it could be interpreted as evidence that some genes are differentially expressed across 
two groups.  
From table 3.2, we can conclude that the theoretical values for the expected number of 
significant genes are the same for different sample sizes and correlations at the same threshold. 
For the different thresholds, the expected values increase as the threshold increases. For the 
standard deviation, it increases as the correlation increases within a threshold. For the empirical 
values from t-tests and randomization tests, they are very close to the theoretical values for both 
expected number and standard deviation of significant discoveries. For example, if the threshold 
 
τ  is 0.01 and the sample size is 20, the theoretical expected number of significant genes is 10, 
and the empirical values from the t-test and randomization test are 9.83 and 9.78 for the 
uncorrelated structure, 9.54 and 9.59 for the moderate correlation, and 10.51 and 10.51 for the 
strong correlation, respectively. For a threshold of 0.01 and n = 20, the empirical values for 
standard deviation are 3.01, 7.77, and 14.53 for t-tests and 3.01, 7.69, and 14.35 for 
randomization tests as the correlation increases. These values are close to the theoretical values. 
In addition, we can see that the empirical values for the standard deviation increase within the 
same correlation structure as the threshold increases. When the correlation 
 
ρ  is 0 and the sample 
size is 20, the theoretical values for standard deviation are 3, 7, and 9, respectively, for different 
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thresholds. The corresponding empirical values are 3.01, 6.51, and 9.67 for the t-tests and 3.01, 
6.37, and 9.46 for the randomization tests. Also, we can conclude that the randomization tests 
produced results similar to that of t-tests based on the empirical values of the expected number 
and standard deviation for the number of significant discoveries. 
In cases 7-12, 25% of the genes were simulated differentially expressed across the two 
treatments. For the genes chosen to be differentially expressed, data were generated using a mean 
corresponding to the effect size of 1.58 on the standard normal scale. When the alternative 
hypothesis was true, the empirical values were compared for the expected number and standard 
deviation of significant discoveries from both t-tests and randomization tests. We did not have a 
formula for the expected number or standard deviation of number of discoveries when the 
alternative hypothesis is true for some genes. 
From table 3.3, we can see that the empirical values for the expected number of 
significant results increase as the threshold increases within a sample size and correlation 
structure. For example, when the sample size is 20 and correlation is 0, the expected values from 
the t-tests are 43.88, 122.50, and 190.96 with the increasing thresholds, and they are 43.71, 
122.37, and 191.06 for the randomization tests. Also, the empirical values for the expected 
number are close for different sample sizes and correlations at the same threshold. For instance, 
at the threshold 0.01, the expected values from the t-tests are 43.88 for the uncorrelated structure, 
43.15 for the moderate correlation, and 38.61 for the strong correlation, and they are 43.71, 
43.05, and 38.54, respectively, from the randomization tests. In addition, the empirical values 
exceed the theoretical values for expected number of significant results under the global null 
hypothesis, which indicates that there are some genes differentially expressed between two 
treatment groups. For the standard deviation, it has the same pattern as the cases under the global 
null hypothesis. The standard deviation increases as the correlation structure becomes stronger. 
For example, when the sample size is 20 and the threshold is 0.01, the empirical values for 
standard deviation are 5.65, 17.22, and 26.62 from the t-tests and 5.60, 17.06, and 26.59 from the 
randomization tests as the correlation increases. Also, the standard deviation increases within the 
same correlation structure as the threshold increases. For instance, when the sample size is 20 
with the uncorrelated structure, the empirical values for standard deviation are 5.65, 8.16, and 
11.95 from the t-tests and 5.60, 8.30, and 11.77 from the randomization tests with the increasing 
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thresholds. In addition, from the table we can also conclude that the randomization tests produce 
similar results to t-tests, just like cases 1 – 6 under the global null hypothesis. 
 
Table 3.2 Simulation Results for Cases 1-6 
For E(No) and Sd(No), the numbers of the first column are the theoretical values for 
different thresholds. The last two columns are the empirical values from t-tests and 
randomization tests respectively. 
Cases SS ES ρ  τ  E(No) Sd(No) 
theor. t-test rand.test theor. t-test rand.test 
1 20 0 0 0.1 100 98.98 98.81 9 9.67 9.46 
0.05 50 49.53 49.52 7 6.51 6.37 
0.01 10 9.83 9.78 3 3.01 3.01 
2 20 0 0.3 0.1 100 96.99 97.07 33 32.92 32.85 
0.05 50 48.35 48.43 23 21.69 21.79 
0.01 10 9.54 9.59 8 7.77 7.69 
3 20 0 0.6 0.1 100 103.37 103.38 65 61.91 61.65 
0.05 50 52.06 52.12 45 41.59 41.35 
0.01 10 10.51 10.51 17 14.53 14.35 
4 10 0 0 0.1 100 100.90 100.79 9 9.63 9.59 
0.05 50 50.43 50.37 7 7.08 7.11 
0.01 10 10.20 10.23 3 3.35 3.24 
5 10 0 0.3 0.1 100 99.38 99.28 33 27.15 27.24 
0.05 50 49.12 49.07 23 17.28 17.29 
0.01 10 9.33 9.39 8 5.70 5.58 
6 10 0 0.6 0.1 100 98.64 98.32 65 68.30 68.18 
0.05 50 49.52 49.46 45 48.05 48.02 
0.01 10 10.52 10.51 17 19.52 19.76 
 
 
15 
 
Table 3.3 Simulation Results for Cases 7-12 
For E(No) and Sd(No), the first column is the empirical values from t-tests and the second 
is the values from randomization tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cases SS ES ρ  τ  E(No) Sd(No) 
t-test rand.test t-test rand.test 
7 20 1.58 0 0.1 190.96 191.06 11.95 11.77 
0.05 122.50 122.37 8.16 8.30 
0.01 43.88 43.71 5.65 5.60 
8 20 1.58 0.3 0.1 189.51 189.70 36.78 36.51 
0.05 120.50 120.28 30.36 30.21 
0.01 43.15 43.05 17.22 17.06 
9 20 1.58 0.6 0.1 183.42 183.36 59.77 59.93 
0.05 114.66 114.37 49.15 49.06 
0.01 38.61 38.54 26.62 26.59 
10 10 1.58 0 0.1 185.63 185.53 11.60 11.68 
0.05 117.15 117.25 9.88 9.88 
0.01 38.31 38.00 5.73 5.65 
11 10 1.58 0.3 0.1 185.39 185.39 38.17 38.14 
0.05 115.72 115.84 32.13 32.22 
0.01 38.63 38.29 18.24 18.11 
12 10 1.58 0.6 0.1 182.83 182.78 61.24 61.21 
0.05 113.56 113.63 48.95 49.15 
0.01 36.41 36.09 26.10 25.97 
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In cases 13-18, 25% of the genes were simulated differentially expressed using a mean 
corresponding to an effect size of 3.16 on the standard normal scale. From table 3.4, we can 
conclude that the pattern of empirical values for the expected number is similar to the cases with 
an effect size of 1.58. It increases as the threshold increases within a sample size and correlation 
structure, and the values are very similar for different sample sizes and correlations at the same 
threshold. However, the magnitude of the expected values is greater than the cases with an effect 
size of 1.58 with the same parameters. For example, when the sample size is 20 and the 
correlation is 0, the expected values are 175.65 and 175.56 respectively for a t-test and 
randomization test at a threshold of 0.01, while they are only 43.88 and 43.71 when the effect 
size is 1.58. For the standard deviation, it increases as the correlation increases within the same 
threshold. However, as the threshold increases within the same correlation, it is not always 
increasing like the cases with an effect size of 1.58. Take the case with a sample size of 20 and 
correlation of 0.3 for an example, the values of the standard deviation are 21.77, 17.45, and 
21.28 for the t-tests and 21.93, 17.56, and 21.44 for the randomization tests with increasing 
thresholds. This discrepancy may be due to simulation error in that only 200 simulations per case 
were carried out. Increasing this number may help to resolve this issue, and it will be left for 
future work. In addition, based on the empirical values from the t-tests and randomization tests, 
we can conclude that the randomization tests produce similar results to that of the t-tests like the 
cases described above. 
Figure 3.2 illustrates the changing pattern for the standard deviation of the number of 
significant results visually. The red line represents the theoretical values under the global null 
hypothesis. The blue represents the empirical values from t-tests and the green is the empirical 
values from randomization tests. From the figures, we can see that the standard deviation 
increases as the correlation increases. Also, it becomes greater when the threshold increases 
within the same correlation except cases with an effect size of 3.16. For the empirical values 
from the two tests, they are so similar that the blue lines and green lines overlap and exist almost 
as the same line. 
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Table 3.4 Simulation Results for Cases 13-18 
For E(No) and Sd(No), the first column is the empirical values from t-tests and the second 
is the values from randomization tests. 
Cases SS ES ρ  τ  E(No) Sd(No) 
t-test rand.test t-test rand.test 
13 20 3.16 0 0.1 306.84 306.69 9.46 9.52 
0.05 255.34 255.30 7.85 7.73 
0.01 175.65 175.56 7.72 7.60 
14 20 3.16 0.3 0.1 303.14 303.25 21.28 21.44 
0.05 252.73 252.71 17.45 17.56 
0.01 175.85 175.57 21.77 21.93 
15 20 3.16 0.6 0.1 303.10 303.07 39.11 39.26 
0.05 253.50 253.54 28.62 28.71 
0.01 176.08 176.01 31.31 31.35 
16 10 3.16 0 0.1 303.55 303.52 9.06 9.01 
0.05 247.81 247.96 8.28 8.37 
0.01 159.40 158.64 8.43 8.23 
17 10 3.16 0.3 0.1 303.37 303.28 22.90 22.69 
0.05 247.59 247.50 19.59 19.41 
0.01 159.04 157.78 23.25 23.31 
18 10 3.16 0.6 0.1 308.03 308.12 45.02 44.94 
0.05 249.29 249.11 36.10 35.78 
0.01 157.23 156.32 37.76 37.50 
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Figure 3.2 Comparison of Standard Deviation of the Number of Discoveries 
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 3.3.2 Comparison of P-values between t-tests and randomization tests 
To study the relationship of P-values between the two tests, we compare the P-values 
from both t-tests and randomization tests. Figures 3.3 to 3.6 illustrate the relationship of P-values 
between these two tests. The horizontal axis represents the P-values from the randomization tests 
and the vertical represents those from the t-tests.  
Figure 3.3 is plotted for the P-values of data sets individually in case 1 (SS=20, ES=0, 
 
ρ=0). There are 9 vectors of P-values which are randomly selected from a total of 200 vectors. 
From these figures, we can conclude that the P-values from t-tests and randomization tests are 
highly correlated. One thing is important here, we have to make sure that the P-values from a t-
test and randomization test are calculated for the same data set. In figure 3.3, all points are 
almost on the diagonal line meaning that the P-values are very similar from the two tests. For 
other cases, the plots of P-values have the same pattern as that of case 1 so we do not need to 
describe all of the figures. Thus, the P-values from the t-tests and randomization tests are highly 
correlated, regardless of sample size and/or correlation. 
 
Figure 3.3 Comparison of P-values for 9 Data Sets in cases 1 
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Figures 3.4 to 3.6 are plotted as the mean of 200 vectors of P-values for the cases with a 
sample size of 20. From these figures, we can see that the results of the t-tests and randomization 
tests are highly correlated. For the cases 1-3, which are under the global null hypothesis, the 
range of the mean of P-values is narrower than that of the individual P-values since the variance 
of a mean is smaller than that of an individual P-value. For the cases under the alternative 
hypothesis, there is a gap in the mean of P-values between differentially and non-differentially 
expressed genes because of the shrinkage of variance. For plots of other cases with a sample size 
of 10, the pattern is the same as the cases with a sample size of 20 so we do not display all of the 
figures. 
 
Figure 3.4 Comparison the Mean of P-values for Cases 1-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case 1 ( ρ =0) Case 2 ( ρ =0.3) 
Case 3 ( ρ =0.6) 
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Figure 3.5 Comparison the Mean of P-values for Cases 7-9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Comparison the Mean of P-values for Cases 13-15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
Case 7 ( ρ =0) Case 8 ( ρ =0.3) 
Case 9 ( ρ =0.6) 
 
  
 
  
Case 13 ( ρ =0) Case 14 ( ρ =0.3) 
Case 15 ( ρ =0.6) 
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 3.3.3 Distribution of P-values 
As mentioned in the literature review, when the global null hypothesis is true, the valid P-
values from multiple tests were expected to have a uniform distribution for the uncorrelated 
HDD. In our study, cases 1 and 4 were simulated for the uncorrelated structure (
 
ρ = 0) and under 
the global null hypothesis. The two figures on the first row in figure 3.7 and 3.8 are plotted for 
cases 1 and 4, respectively. One is plotted for the P-values from the t-tests and the other is for the 
randomization tests. Shown are 4 histograms of P-values for each case which were randomly 
selected from a total of 200 vectors. Also, the P-values from the two tests were calculated from 
the same data set. From these figures, we can see that the histogram of P-values is approximately 
uniform on interval 0 and 1 for both cases. However, when the HDD are correlated, the 
distribution of P-values may vary widely from experiment to experiment. The other figures 
describe this pattern visually for the cases which were simulated as correlated HDD and under 
the global null hypothesis. They are not a uniform distribution. In some occasions, there are 
fewer P-values clustering near 0 than the expected under the global null hypothesis, which is 
difficult to interpret. In other occasions, there are many more P-values clustering near 0, which is 
a sign that some genes may be differentially expressed, even though the global null hypothesis is 
true. So, the distribution of P-values from multiple tests can give misleading results when HDD 
are correlated. However, the distribution of P-values is plausible for moderate correlation 
structure. In addition, we can conclude that the pattern of histogram of P-values is very similar 
between the t-tests and randomization tests for all cases under the global null hypothesis.   
When there are some genes differentially expressed across two treatments, the 
distribution of P-values shows a clustering near 0. Figures 3.9 to 3.12 are plotted for the cases 
under the alternative hypothesis. Figures 3.9 and 3.10 display the distribution of P-values for the 
cases with an effect size of 1.58, and figures 3.11 and 3.12 are plotted for the cases with an effect 
size of 3.16. From these figures, we can see that the P-values are more likely to cluster near 0 for 
the uncorrelated data when the alternative is true. For the correlated HDD, the P-values also 
show a pattern of clustering near 0. However, the signal is stronger for the effect size of 3.16 
compared to 1.58. In addition, we can see that the distribution of P-values is very similar 
between the sample size of 10 and 20 with the same parameters. What is more important, it can 
be concluded that the histograms of P-values are also similar between the t-tests and 
randomization tests for the cases under the alternative hypothesis.  
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Figure 3.7 Histograms of P-values for Cases 1-3 (SS=20 ES=0) 
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Figure 3.8 Histograms of P-values for Cases 4-6 (SS=10 ES=0) 
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Figure 3.9 Histograms of P-values for Cases 7-9 (SS=20 ES=1.58) 
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Figure 3.10 Histograms of P-values for Cases 10-12 (SS=10 ES=1.58) 
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Figure 3.11 Histograms of P-values for Cases 13-15 (SS=20 ES=3.16) 
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Figure 3.12 Histograms of P-values for Cases 16-18 (SS=10 ES=3.16) 
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Chapter 4 - A Real Case Study 
In this report, a real microarray dataset was used to illustrate the results comparing the 
randomization tests with t-tests. 
 4.1 Multiple Myeloma and Bone Lesions Dataset 
A microarray dataset in multiple myeloma patients with and without bone lesions was 
introduced in Tian et al (2003). There were 173 individuals in total. 137 subjects were with bone 
lytic lesions and 36 of them were without bone lytic lesions. To obtain the data at the gene 
expression level, U95Av2 microarrays were used for hybridization , and MAS software, version 
5.01, was used to quantify the intensity values (referred to as signals). After initial filtration, the 
number of probe sets was reduced to 3970.  
 4.2 Results for Multiple Myeloma Dataset 
In this microarray study, of interest was to detect the genes differentially expressed across 
the two treatment conditions. The number of false positive results among the rejected null 
hypotheses need to be controlled. As mentioned in the literature review, FDR controls the 
expected proportion of false discoveries among the rejected null hypotheses.  
For the real case study, the quantities of interests and analysis are similar to that of the 
simulation study. First, the P-values were calculated for each gene by a randomization test and t-
test, respectively. Then, based on the P-values, we computed the q-values. Finally, we assessed 
the performance of a randomization test compared with a t-test. 
 4.2.1 Comparison of P-values and q-values between the t-tests and randomization tests 
To study the relationship of P-values and q-values between the t-tests and randomization 
tests, the results from these two tests were compared. Figure 4.1 displays this comparison for the 
P-values and q-values, respectively. The left figure is plotted for the P-values and the right is for 
the q-values. The horizontal axis represents the results of randomization tests and the vertical 
represents those of t-tests. From these figures, we can conclude that the results are highly 
correlated between a randomization test and t-test. The correlation is 0.995 for P-values and 
0.894 for q-values, respectively, between these two tests. In addition, we can see that the number 
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of points in the circled area is less for the plot of q-values than that of P-values since a q-value 
corresponds to a P-value that has been adjusted for FDR control.  For example, 5% FDR means 
that among the significant discoveries, 5% are true nulls.  
 
Figure 4.1 Comparisons for P-values and q-values 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 4.2.2 Distribution of P-values and q-values 
Figures 4.2 and 4.3 are plotted for the histograms of P-values and q-values from both t-
test and randomization test. From these figures, we can conclude that the histogram patterns are 
very similar between these two tests for this case study. Also, based on the cumulative number of 
significant calls (table 4.1) derived from the two tests, we can see that the values are close at the 
different thresholds. In addition, from the histograms of P-values, we can see that the P-values 
are more likely to cluster near 0, which is a sign that some genes may be differentially expressed 
between two treatments. Based on the study of correlation densities in Paranagama (2011), the 
departure of the correlation distribution from independence is subtle for this data set. Thus, we 
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can make a conclusion that there are some genes differentially expressed across two disease state 
sets. 
 
Table 4.1 Cumulative Number of Significant Calls 
 P-values q-values 
<0.01  <0.05   <0.1    <0.01  <0.05   <0.1    
T-test 203 514 773 10 79 119 
Randomization test    201 497 770 35 72 131 
 
 
Figure 4.2 Histograms of P-values 
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Figure 4.3 Histograms of q-values 
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Chapter 5 - Concluding Remarks and Future Work 
In this report, we focused on the comparison of randomization tests with usual t-tests to 
assess the performance of randomization tests in the presence of non-estimable dependence 
structure. The dependence structure cannot be estimated since the number of features is very 
large relative to the available samples. For a randomization setting, it is column-wise 
permutation across treatment conditions which helps preserve the correlation structure between 
genes. In addition, the results from simulations and a real case study showed that the 
randomization tests produced similar results to that of t-tests. For uncorrelated data, the P-values 
were valid since the correct reference distribution was used for the test statistics, and the 
distribution of them was meaningful to analyze the HDD. However, when HDD are not 
independent, the results may be misleading when illustrating biological results using the 
distribution of the P-values. So, we can make a conclusion that randomization tests are no direct 
assistance with the correlation effects in HDD.  
For a correlation study, it is unrealistic to estimate a (K×K)-dimensional dependence 
structure from observed data on available sample units. However, we can estimate the correlation 
between any pair of genes to determine the presence of apparent structure and the extent of a 
departure from an independence structure. So, for future work, we can study the empirical 
pairwise-correlations between genes to evaluate the performance of randomization tests in the 
presence of a dependence structure. 
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Appendix A - R Programs 
############################################################################## 
## 
##    Function to generate correlated HDD employing basic block diagonal covariance matrices. 
## 
##    Input: 
##       m -- the number of rows (genes), n -- the number of columns (sample size),  
##       rol -- the correlation coefficient, b -- the block size, u -- the value to form the mean vector. 
## 
##     Output: 
##       a matrix (m
 
×n) with a correlation of rol within the block. 
## 
############################################################################## 
  
 normdata<-function(m,n,rol,b,u){ 
 
 R1<-matrix(rol,b,b) 
 R2<-diag(1-rol,b) 
 R<-R1+R2 
 cov<-R 
 X<-rep(0,n) 
 
 for(i in 1:(m/b)){ 
 x<-rmvnorm(n=n,mean=c(rep(u,50),rep(0,b-50)),sigma=cov) 
 X<-cbind(X,x) 
 } 
 
 X<-X[,-1] 
 y<-t(X) 
 y<<-y 
  
} 
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############################################################################## 
## 
##    This code computes P-values for an input data set using t-tests. 
## 
##    Input:   
##         data -- a data matrix with k rows and 2n columns.  
##         k is the number of genes. It is assumed there are  
##         two groups with n cases in each group. 
## 
##    Output: pval-- a permanent object. 
## 
############################################################################## 
 
Pval.code<-function(data){ 
    
   n<-dim(data)[1] 
   num<-dim(data)[2]/2 
   sum1<-0 
   sum2<-0 
   sum1.2<-0 
   sum2.2<-0 
 
   for(i in 1:num){ 
   sum1<-data[,i]+sum1 
   sum2<-data[,(num+i)]+sum2 
   sum1.2<-sum1.2+data[,i]^2 
   sum2.2<-sum2.2+data[,(num+i)]^2 
   } 
 
   mu1<-sum1/num 
   mu2<-sum2/num 
   var1<-(sum1.2-num*mu1^2)/(num-1) 
   var2<-(sum2.2-num*mu2^2)/(num-1) 
   sd.cr<-sqrt((var1+var2)/num) 
   #sd.cr1<<-sd.cr 
   tstat<-(abs(mu1-mu2)/sd.cr) 
   #print(mean(tstat)) 
   #using pooled degrees of freedom here 
   pval<-(1-pt(tstat,(2*num-2)))*2 
   pval<<-pval 
  
   } 
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############################################################################## 
## 
##    This code does an approximate randomization test for two sample data. 
## 
##    Input: 
##         data -- a data matrix with k rows (genes) and 2n columns (samples). The first n=N/2  
##         columns are one treatment group, and the second n=N/2 columnes is the  
##         second treatment group. 
##         its -- the number of iterations desired. 
## 
##     Output: 
##          pval-- a permanent object. 
## 
############################################################################## 
 
Pval.rand.approx<-function(data,its){ 
pval<-0 
k<-dim(data)[1] 
N<-dim(data)[2] 
n<-N/2 
R.Test<-rep(0,k) 
 
sum1<-0 
sum2<-0 
 
for(i in 1:n){ 
sum1<-data[,i]+sum1 
sum2<-data[,(n+i)]+sum2 
} 
 
mu1<-sum1/n 
mu2<-sum2/n 
d.obs<-mu1-mu2 
d.obs<-round(d.obs,4) 
d.obs<<-d.obs 
 
for(j in 1:its){ 
tt<-sample(c(rep(1,n),rep(0,n))) 
x<-data[,tt==1] 
y<-data[,tt==0] 
sum1a<-0 
sum2a<-0 
 
for(i in 1:n){ 
sum1a<-x[,i]+sum1a 
sum2a<-y[,i]+sum2a 
40 
 
} 
 
mu1a<-sum1a/n 
mu2a<-sum2a/n 
d.rand<-mu1a-mu2a 
d.rand<-round(d.rand,4) 
test<-rep(0,k) 
test[abs(d.rand)>=abs(d.obs)]<-1 
R.Test<-R.Test+test 
} 
 
pval<-R.Test/its 
pval<<-pval 
 
} 
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############################################################################## 
## 
##    Function computing the theoretical values for the standard deviation of the  
##    number of significant discoveries. 
##     
##    Input: 
##         r -- correlation coefficient within a block. 
##         a -- thresholds. 
##         k -- block size. 
##         m -- number of blocks. 
##  
##    Output: 
##          matrix with columns the threshold, the variance for the number of  
##          significant tests in one block of size k, and the standard deviation  
##          for the number of significant discoveries out of k*m genes. 
## 
############################################################################## 
 
library(mvtnorm) 
 
testvar=function(r,a=c(.2,.15,.1,.05,.01,.001,.0001),k,m){ 
 
 n=length(a) 
 res=rep(0,n) 
  
 for(i in 1:n){ 
  rho=cbind(c(1,r),c(r,1)) 
  ai=a[i] 
  t=qnorm(1-ai/2) 
  print(c(ai,t)) 
  #compute covariance assuming equal correlations among all pairs 
  p=pmvnorm(upper=c(t,t),corr=rho)-pmvnorm(upper=c(t,-t),corr=rho)-pmvnorm(upper=c(-
t,t),corr=rho)+pmvnorm(upper=c(-t,-t),corr=rho) 
  v1=k*ai*(1-ai) 
  v2=k*(k-1)*(p[[1]]-(1-ai)^2) #variance of number of rejection 
  v=v1+v2 
  res[i]=v 
 } 
 
 sd=sqrt(m*res) 
 return(cbind(a,res,sd)) 
} 
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############################################################################## 
## 
##    This function is to plot the p-values (t-test vs rand.test) for 1000 
##    genes in individual data set. There are 9 vectors of P-values which are randomly  
##    selected from a total of 200 simulations. 
## 
##    Input: 
##         p.t -- p-values from t-tests. 
##         p.rand -- p-values from randomization tests for the same data set as t-tests. 
## 
##    Output: 
##          produce figure 3.2. 
## 
############################################################################## 
 
image.plot<-function(p.t,p.rand){ 
 
 par(mfrow=c(3,3)) 
 
 for (i in 1:9){ 
 j=sample(1:200,1) 
    x=p.rand[,j] 
 y=p.t[,j] 
 plot(x,y,xlim=c(0,1),ylim=c(0,1),xlab="p-value randomization test",ylab="p-value t-test") 
 } 
 
} 
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############################################################################## 
## 
##    This function is to plot the histogram of p-values for 1000 
##    genes in individual data set. There are 4 vectors of P-values which are randomly  
##    selected from a total of 200 simulations. 
## 
##    Input: 
##         p.vector -- a vector of P-values for 1000 genes. 
## 
##    Output: 
##         a histogram of P-values. 
## 
############################################################################## 
 
hist.plot<-function(p.vector){ 
 
 par(mfrow=c(2,2)) 
 
 for (i in 1:4){ 
  j=sample(1:200,1) 
  x=p.matrix[,j] 
  hist(x,freq=FALSE,main="",xlim=c(0,1),xlab="",ylab="") 
 }  
 
}  
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#################################################################### 
## 
##    Function for performing row-wise t-tests for a given matrix  
##    (works for unequal sample size). Grouping variable must be provided  
##    separately and is used to group columns in the data matrix. 
## 
##    Input:  
##          data1 -- subjects in columns and variables in rows.  
##          groups -- grouping variable used to group subjects. 
##  
##    Output:  
##          matrix with columns t-statistic values, p-values and degrees of freedom.  
## 
##################################################################### 
 
rowttest<-function(data1, groups) {  
 
dottest<-function(d, g) {  
x<-d[g==unique(g)[1]]  
y<-d[g==unique(g)[2]]  
t<-t.test(x, y, alternative="two.sided")  
c(t.stat=t$statistic, p.val=t$p.value, df=t$parameter)  
}  
 
t(apply(X=data1, MARGIN=1, FUN=dottest, g=groups))  
} 
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#########################################################################  
## 
##    Function for computing an approximate p-value for a randomization test  
##    for two treatments.  
## 
##    Input:  
##         X -- a vector of responses of units to a control treatment. 
##         Y -- a vector of responses of units to a test treatment. 
##         its -- the number of iterations desired. 
##  
##    Output:  
##         a list object, say r,  with D and P.  
##         d is the observed treatment different. 
##         p is  the approximated p-value for randomization test. 
##  
######################################################################### 
  
random.approx<-function(X,Y,its){ 
 
 XY<-c(X,Y) 
 N<-length(XY) 
 n1=length(X) 
 d<-mean(Y)-mean(X) 
  
 D.null<-0 
  
 for (i in 1:its){ 
  treat<-sample(1:N,n1) 
  d.null<-mean(XY[treat])-mean(XY[-treat]) 
  D.null[i]<-d.null 
 } 
  
 d<-d 
 D.null<-D.null 
 pval<-sum(abs(D.null)>=abs(d))/its 
  
r=list(D=d,P=pval) 
r 
  
} 
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#########################################################################  
##  
##    Function for performing row-wise randomization tests for a given matrix  
##    (works for unequal sample size). Grouping variable must be provided separately 
##    and is used to group columns in the data matrix.  
## 
##    Input:  
##         data1 -- subjects in columns and variables in rows.  
##         groups -- grouping variable used to group subjects.  
## 
##    Output:  
##          matrix with columns observed treatment difference and p-values.  
##  
#########################################################################  
 
 
row.rand.test<-function(data1,groups){ 
  
 do.rand.test<-function(d,g){ 
  x<-d[g==unique(g)[1]] 
  y<-d[g==unique(g)[2]] 
  rand<-random.approx(x,y,10000) 
  c(obs.d=rand$D, p.val=rand$P) 
 } 
  
 t(apply(data1,MARGIN=1, FUN=do.rand.test, g=groups)) 
 
} 
 
 
 
 
